Microbial platform technology for recombinant antibody fragment production: A review.
about
Recent Developments in Systems Biology and Metabolic Engineering of Plant-Microbe Interactions.A combination of HPLC and automated data analysis for monitoring the efficiency of high-pressure homogenizationSophisticated Cloning, Fermentation, and Purification Technologies for an Enhanced Therapeutic Protein Production: A Review.Expression Optimization of Anti-CD22 scFv-Apoptin Fusion Protein Using Experimental Design MethodologyProduction of an anti-Aβ antibody fragment in Pichia pastoris and in vitro and in vivo validation of its therapeutic effect.Over-expression of a Codon Optimized Yeast Cytosolic Pyruvate Carboxylase (PYC2) in CHO Cells for an Augmented Lactate Metabolism.Biotherapeutic potential and mechanisms of action of colchicine.Metabolic engineering of CHO cells for the development of a robust protein production platform.Single-Domain Antibodies As Versatile Affinity Reagents for Analytical and Diagnostic Applications.Mechanistic platform knowledge of concomitant sugar uptake in Escherichia coli BL21(DE3) strains.An Alkaline Protease from Bacillus pumilus MP 27: Functional Analysis of Its Binding Model toward Its Applications As Detergent Additive.Impact of Glycerol as Carbon Source onto Specific Sugar and Inducer Uptake Rates and Inclusion Body Productivity in E. coli BL21(DE3).Bovine single chain Fv antibody inhibits bovine herpesvirus-1 infectivity by targeting viral glycoprotein D.Cell Line Techniques and Gene Editing Tools for Antibody Production: A Review.Proteomic approaches in microalgae: perspectives and applications.Custom made inclusion bodies: impact of classical process parameters and physiological parameters on inclusion body quality attributes
P2860
Q28075566-94D44117-634E-4E80-ADE0-5AE62F43A914Q38648450-1C58C384-8BF6-4A4A-87B6-29314935A5DCQ38654852-8354ECE9-6BF9-4733-9081-7FC170FC8D18Q38660840-3F26D872-A591-4847-9300-E71A22C5D1ADQ38695811-4864A974-B39D-49CE-AA15-9E7BF4DFE11BQ38695847-A4CCF995-89CC-4CC4-B409-55CA903D2110Q39258157-DC761FD0-52BD-4D1B-832E-E3A8252E9F6FQ41200443-01C9E76B-569A-4F8D-8165-FA00721B23A3Q41484905-7C1B3FBB-EE1C-49F3-9071-BE2863A7E97CQ42314659-B59D5286-0CEB-4769-8FAE-6D9AC90690CCQ42385227-F910435E-3A14-411F-9E32-631C272BC910Q47228220-76DCBA3D-BFC3-4F5D-83DF-6A9E485E7BEFQ47602852-802D3202-FC92-4AFA-8E71-327743FC7ED0Q55333943-7B1A9B5C-D17A-4DDB-AA45-33482EC616A2Q55517837-73E84430-2F0E-42B8-9A13-6CCE9EE8C56BQ58712006-61C81833-0657-4412-B96E-9D01CFEF86DC
P2860
Microbial platform technology for recombinant antibody fragment production: A review.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Microbial platform technology for recombinant antibody fragment production: A review.
@en
type
label
Microbial platform technology for recombinant antibody fragment production: A review.
@en
prefLabel
Microbial platform technology for recombinant antibody fragment production: A review.
@en
P2860
P1476
Microbial platform technology for recombinant antibody fragment production: A review.
@en
P2093
Pratyoosh Shukla
Sanjeev Kumar Gupta
P2860
P356
10.3109/1040841X.2016.1150959
P407
P577
2016-07-07T00:00:00Z